PEDIATRIC ONCOLOGY GROUP--THE CAROLINAS CONSORTIUM
PEDIATRIC ONCOLOGY GROUP--THE CAROLINAS CONSORTIUM
批准号:
6489242
负责人:
JULIO C BARREDO
金额:
$6.16万
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-06-15 至 2002-12-31
关键词:
6 thiopurine Ewing's tumor Hodgkin's disease Wilms' tumor XomaZyme acivicin acute leukemia acute lymphocytic leukemia acute myelogenous leukemia adolescence (12-20) antineoplastics asparaginase astrocytoma biological response modifiers bone marrow transplantation brain neoplasms cancer registry /resource cancer risk central nervous system neoplasms child (0-11) chronic myelogenous leukemia cis platinum compound clinical research clinical trial phase I colony stimulating factor combination cancer therapy combination chemotherapy cooperative study cyclophosphamide cyclosporines cytosine arabinoside daunorubicin deferoxamine deoxycoformycin doxorubicin drug screening /evaluation enalapril ependymoma etoposide fazarabine fluorouracil germ cell neoplasms glioma hepatoblastoma hepatocellular carcinoma human genetic material tag human immunodeficiency virus 1 human subject human therapy evaluation human tissue ifosfamide interferons interleukin 2 medulloblastoma melphalan metastasis methotrexate minimal residual disease mitoxantrone molecular oncology neoplasm /cancer chemotherapy neoplasm /cancer classification /staging neoplasm /cancer epidemiology neoplasm /cancer genetics neoplasm /cancer immunology neoplasm /cancer immunotherapy neoplasm /cancer pharmacology neoplasm /cancer radiation therapy neoplasm /cancer surgery neuroblastoma nonHodgkin's lymphoma osteosarcoma paclitaxel pediatric pharmacology podophyllin prednisone retinoate rhabdomyosarcoma tetrahydrofolylpolyglutamate synthase tissue resource /registry topotecan trimetrexate vincristine
中文摘要
描述(根据申请人描述改编):机构
英文摘要
DESCRIPTION (Adapted from the applicant's description): The institutions
included in this proposal have been part of the Pediatric Oncology Group
(POG) and received good performance scores during the past five years.
There are two primary goals of this proposed research; the first is to
accrue patients to the Group clinical trials in order to determine the
optimal care of children with all types of cancers. The second is to
contribute scientific expertise to the Group in areas of both patient care
and tumor biology. This proposed research will allow participation in POG
activities through a consortium effort of East Carolina University (ECU)
School of Medicine, Carolinas Medical Center, Medical University of South
Carolina (MUSC), Greenville Hospital, Presbyterian Hospital, and Memorial
Mission Hospital (The Carolinas' Consortium). In addition to these clinical
activities, their scientific efforts in next five years will include: (1)
development of new protocols for the treatment of children with cancer
focusing mainly on pediatric lymphomas; (2) expansion of studies of minimal
marrow residual disease (using RT-PCR analysis) and assessment of new
purging techniques in neuroblastoma; (3) participation in the laboratory
evaluation of folylpolyglutamate synthetase (FPGS) in lymphoblasts of newly
diagnosed patients; and (4) evaluation of the role hematopoietic growth
factors in the treatment of pediatric malignancies.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Effects of cranial radiation in children with high risk T cell acute lymphoblastic leukemia: a Pediatric Oncology Group report.
颅脑放射对高危 T 细胞急性淋巴细胞白血病儿童的影响:儿科肿瘤学小组报告。
DOI:
10.1038/sj.leu.2401693
发表时间:
2000
期刊:
Leukemia
影响因子:
11.4
作者:
[Laver,JH, Barredo,JC, Amylon,M, Schwenn,M, Kurtzberg,J, Camitta,BM, Pullen,J, Link,MP, Borowitz,M, Ravindranath,Y, Murphy,SB, Shuster,J]
通讯作者:
Shuster,J
New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a pediatric oncology group report of 343 cases.
新的复发性细胞遗传学异常以及母细胞核型与儿童 T 细胞急性淋巴细胞白血病预后的关联:儿科肿瘤学小组 343 例报告。
DOI:
--
发表时间:
2000
期刊:
Blood
影响因子:
20.3
作者:
[Schneider,NR, Carroll,AJ, Shuster,JJ, Pullen,DJ, Link,MP, Borowitz,MJ, Camitta,BM, Katz,JA, Amylon,MD]
通讯作者:
Amylon,MD
Interobserver variability in the detection of cervical-thoracic Hodgkin's disease by computed tomography.
计算机断层扫描检测颈胸霍奇金病的观察者间差异。
DOI:
10.1200/jco.1999.17.7.2153
发表时间:
1999
期刊:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
影响因子:
--
作者:
[Fletcher,BD, Glicksman,AS, Gieser,P]
通讯作者:
Gieser,P
Oral methotrexate for recurrent brain tumors in children: a Pediatric Oncology Group study.
口服甲氨蝶呤治疗儿童复发性脑肿瘤:一项儿科肿瘤学小组研究。
DOI:
10.1097/00043426-200001000-00008
发表时间:
2000
期刊:
Journal of pediatric hematology/oncology
影响因子:
--
作者:
[Mulne,AF, Ducore,JM, Elterman,RD, Friedman,HS, Krischer,JP, Kun,LE, Shuster,JJ, Kadota,RP]
通讯作者:
Kadota,RP
Results of a randomized phase III trial in children and adolescents with advanced stage diffuse large cell non-Hodgkin's lymphoma: a Pediatric Oncology Group study.
对患有晚期弥漫性大细胞非霍奇金淋巴瘤的儿童和青少年进行的随机 III 期试验的结果:一项儿科肿瘤学小组研究。
DOI:
10.1080/10428190210192
发表时间:
2002
期刊:
Leukemia & lymphoma
影响因子:
2.6
作者:
[Laver,JosephH, Mahmoud,Hazem, Pick,TerryE, Hutchison,RobertE, Weinstein,HowardJ, Schwenn,Molly, Weitzman,Sheilah, Murphy,SharonB, Ochoa,Stephanie, Shuster,JonathanJ]
通讯作者:
Shuster,JonathanJ
共 6 条
PEDIATRIC HYDROXYUREA PHASES III CLINICAL TRIAL - BABY HUG
-
批准号:7204998
-
项目类别:
-
资助金额:$1.72万
-
财政年份:2005
-
负责人:JULIO C BARREDO
-
依托单位:
Molecular Determinants of Methotrexate in ALL
-
批准号:6885795
-
项目类别:
-
资助金额:$29.93万
-
财政年份:2004
-
负责人:JULIO C BARREDO
-
依托单位:
Pediatric Hydroxyurea Phase III Clinical Trial
-
批准号:7043481
-
项目类别:
-
资助金额:$0.31万
-
财政年份:2004
-
负责人:JULIO C BARREDO
-
依托单位:
Molecular Determinants of Methotrexate in ALL
-
批准号:7333720
-
项目类别:
-
资助金额:$23.18万
-
财政年份:2004
-
负责人:JULIO C BARREDO
-
依托单位:
Molecular Determinants of Methotrexate in ALL
-
批准号:6778681
-
项目类别:
-
资助金额:$29.93万
-
财政年份:2004
-
负责人:JULIO C BARREDO
-
依托单位:
Molecular Determinants of Methotrexate in Acute Lymphoblastic Leukemia
-
批准号:7413378
-
项目类别:
-
资助金额:$29.74万
-
财政年份:2004
-
负责人:JULIO C BARREDO
-
依托单位:
Molecular Determinants of Methotrexate in Acute Lymphoblastic Leukemia
-
批准号:7245083
-
项目类别:
-
资助金额:$29.73万
-
财政年份:2004
-
负责人:JULIO C BARREDO
-
依托单位:
Molecular Determinants of Methotrexate in ALL
-
批准号:7050606
-
项目类别:
-
资助金额:$7.03万
-
财政年份:2004
-
负责人:JULIO C BARREDO
-
依托单位:
PEDIATRIC HYDROXYUREA PHASE III CLINICAL TRIAL
-
批准号:7542927
-
项目类别:
-
资助金额:$47.91万
-
财政年份:2000
-
负责人:JULIO C BARREDO
-
依托单位:--
CLINICAL PHENOTYPE TARGETED ANTIFOLATE CHEMOTHERAPY
-
批准号:2871914
-
项目类别:
-
资助金额:$10.08万
-
财政年份:1997
-
负责人:JULIO C BARREDO
-
依托单位:
CLINICAL PHENOTYPE TARGETED ANTIFOLATE CHEMOTHERAPY
-
批准号:2010798
-
项目类别:
-
资助金额:$9.92万
-
财政年份:1997
-
负责人:JULIO C BARREDO
-
依托单位:
CLINICAL PHENOTYPE TARGETED ANTIFOLATE CHEMOTHERAPY
-
批准号:2654243
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1997
-
负责人:JULIO C BARREDO
-
依托单位:
CLINICAL PHENOTYPE TARGETED ANTIFOLATE CHEMOTHERAPY
-
批准号:6150238
-
项目类别:
-
资助金额:$10.17万
-
财政年份:1997
-
负责人:JULIO C BARREDO
-
依托单位:
CLINICAL PHENOTYPE TARGETED ANTIFOLATE CHEMOTHERAPY
-
批准号:6350205
-
项目类别:
-
资助金额:$10.23万
-
财政年份:1997
-
负责人:JULIO C BARREDO
-
依托单位:
PEDIATRIC ONCOLOGY GROUP--THE CAROLINAS CONSORTIUM
-
批准号:6341999
-
项目类别:
-
资助金额:$5.02万
-
财政年份:1996
-
负责人:JULIO C BARREDO
-
依托单位: